Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US7998506B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | May 23, 2003 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Aug 22, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An orally administered antihyperlipidemia composition according to the present invention includes from about 250 to about 3000 parts by weight of nicotinic acid, and from about 5 to about 50 parts by weight of hydroxypropyl methylcellulose. Also, a method of treating hyperlipidemia in a hyperlipidemic having a substantially periodic physiological loss of consciousness, includes the steps of forming a composition having an effective antihyperlipidemic amount of nicotinic acid and a time release sustaining amount of a swelling agent. The method also includes the step of orally administering the composition to the hyperlipidemic once per day “nocturnally,” that is in the evening or at night.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.